Earlier extracranial progression and shorter survival in ALK- rearranged lung cancer with positive liquid rebiopsiesPetros Christopoulos(Thorax Foundation), Holger Sültmann(German Cancer Research Center)Translational Lung Cancer ResearchMay 1, 202110.21037/tlcr-21-32Cited by 21SaveCiteExport RISWatch citationsRelated PapersComutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC|Cancer Discovery|2023|181Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer|ESMO Open|2021|93